Harley-Davidson Inc vs Nuwellis Inc — how do they compare? Harley-Davidson Inc trades at $26.75 (market cap $2.78B), while Nuwellis Inc trades at $0.68 (market cap $2.20M). The key difference: Harley-Davidson Inc is far larger — about 1263.6× Nuwellis Inc's market cap, and Harley-Davidson Inc pays a 2.8% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Harley-Davidson Inc for 91 Days and Nuwellis Inc for 26 Days on average.
| HOG | NUWE | |
|---|---|---|
Market Cap | $2.78B | $2.20M |
Volume | 2,966,389 | 121,544 |
Sector | Consumer Cyclical | Health |
52-Week High | $28.46 | $146.65 |
52-Week Low | $17.19 | $0.68 |
Typical Hold Time | 91 Days | 26 Days |
Enterprise Value | $3.20B | -$1.52M |
Dividend Yield | 2.8% | — |
Signals from Pluang's Aura AI — not financial advice
Harley-Davidson (HOG) trades at $26.95, up 0.04% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $28.50. Recent Q2 2026 earnings beat expectations, but revenue has declined from $5.8B in 2022 to $4.5B in 2025, with net income margin falling to 7.57%. The company maintains a dividend and shows improved cash flow trends, though it faces headwinds from tariffs and a recent data breach investigation.
The stock presents a mixed outlook: valuation metrics like P/E of 14.97 and P/B of 0.9 suggest potential upside, but declining profitability and competitive pressures pose risks. Investor sentiment is cautious with 61% hold ratings, while institutional activity shows mixed positioning. Key catalysts include execution of the 'Back to the Bricks' strategy, though tariff exposures and softening demand remain concerns.
NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.
The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Harley-Davidson is a global leading manufacturer of heavyweight motorcycles, merchandise, parts, and accessories. It sells custom, cruiser, and touring motorcycles and offers a complete line of Harley-Davidson motorcycle parts, accessories, riding gear, and apparel, as well as merchandise. Harley-Davidson Financial Services provides wholesale financing to dealers and retail financing and insurance brokerage services to customers. Harley has historically captured about half of all heavyweight domestic retail motorcycle registrations, a metric it had ceded in 2020 as it repositioned the business, but a level it is working back toward. In recent years the firm has expanded into the adventure touring market with its Pan America model and into electric with the LiveWire brand.
Read more on HOG →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →